drugset / Trial / NCT02807987
Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment
NaSingle-groupOpen-labelTreatment
Summary
To examine antihypertensive effect and safety of administration of CS-3150 in combination with ARB or ACE inhibitor in hypertensive patients with moderate renal impairment.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-05-15
- Completion
- 2017-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CS-3150 | Unknown | 1.25 mg | Oral |
| Subject | CS-3150 | Unknown | 2.5 mg | Oral |
| Subject | CS-3150 | Unknown | 5 mg | Oral |